104 related articles for article (PubMed ID: 28790196)
1. TRIF-dependent Toll-like receptor signaling suppresses
Chen J; Li J; Yiu JHC; Lam JKW; Wong CM; Dorweiler B; Xu A; Woo CW
Sci Signal; 2017 Aug; 10(491):. PubMed ID: 28790196
[TBL] [Abstract][Full Text] [Related]
2. Role of Adaptor Protein Toll-Like Interleukin Domain Containing Adaptor Inducing Interferon β in Toll-Like Receptor 3- and 4-Mediated Regulation of Hepatic Drug Metabolizing Enzyme and Transporter Genes.
Shah P; Omoluabi O; Moorthy B; Ghose R
Drug Metab Dispos; 2016 Jan; 44(1):61-7. PubMed ID: 26470915
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy.
Zhou Y; Zhong L; Yu S; Shen W; Cai C; Yu H
Aging (Albany NY); 2020 Apr; 12(8):7350-7362. PubMed ID: 32324591
[TBL] [Abstract][Full Text] [Related]
4. TIR Domain-Containing Adaptor-Inducing Interferon-β (TRIF) Participates in Antiviral Immune Responses and Hepatic Lipogenesis of Large Yellow Croaker (
Zhu S; Xiang X; Xu X; Gao S; Mai K; Ai Q
Front Immunol; 2019; 10():2506. PubMed ID: 31736951
[TBL] [Abstract][Full Text] [Related]
5. Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.
Geng T; Xia L; Russo S; Kamara D; Cowart LA
Nutr Res; 2015 Sep; 35(9):812-22. PubMed ID: 26277244
[TBL] [Abstract][Full Text] [Related]
6. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
[TBL] [Abstract][Full Text] [Related]
7. TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice.
Yang L; Miura K; Zhang B; Matsushita H; Yang YM; Liang S; Song J; Roh YS; Seki E
Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):469-483. PubMed ID: 28462384
[TBL] [Abstract][Full Text] [Related]
8. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
10. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
[TBL] [Abstract][Full Text] [Related]
11. Suppression of TRIF-dependent signaling pathway of toll-like receptors by allyl isothiocyanate in RAW 264.7 macrophages.
Kim SJ; Park HJ; Shin HJ; Shon DH; Kim DH; Youn HS
Int Immunopharmacol; 2012 Aug; 13(4):403-7. PubMed ID: 22668719
[TBL] [Abstract][Full Text] [Related]
12. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
Li ZZ; Berk M; McIntyre TM; Feldstein AE
J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140
[TBL] [Abstract][Full Text] [Related]
13. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
[TBL] [Abstract][Full Text] [Related]
14. Central role of the TIR-domain-containing adaptor-inducing interferon-β (TRIF) adaptor protein in murine sterile liver injury.
Brempelis KJ; Yuen SY; Schwarz N; Mohar I; Crispe IN
Hepatology; 2017 Apr; 65(4):1336-1351. PubMed ID: 28120431
[TBL] [Abstract][Full Text] [Related]
15. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
16. The TLR signalling adaptor TRIF/TICAM-1 has an N-terminal helical domain with structural similarity to IFIT proteins.
Ullah MO; Ve T; Mangan M; Alaidarous M; Sweet MJ; Mansell A; Kobe B
Acta Crystallogr D Biol Crystallogr; 2013 Dec; 69(Pt 12):2420-30. PubMed ID: 24311583
[TBL] [Abstract][Full Text] [Related]
17. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
Dansako H; Ikeda M; Kato N
FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
[TBL] [Abstract][Full Text] [Related]
18. Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1.
Joung SM; Park ZY; Rani S; Takeuchi O; Akira S; Lee JY
J Immunol; 2011 Jan; 186(1):499-507. PubMed ID: 21106850
[TBL] [Abstract][Full Text] [Related]
19. Suppression of TRIF-dependent signaling pathway of toll-like receptors by (E)-1-(2-(2-nitrovinyl)phenyl)pyrrolidine.
Gu GJ; Eom SH; Suh CW; Koh KO; Kim DY; Youn HS
Eur J Pharmacol; 2013 Dec; 721(1-3):109-15. PubMed ID: 24080550
[TBL] [Abstract][Full Text] [Related]
20. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
